ArticleEuropean heart journal2020
Proceedings from the 3rd European Clinical Consensus Conference for clinical trials in device-based hypertension therapies.
Erratum issued Registry-linked trialOpen access · bronzeAbstract readConsensus Statement
In one paragraph
Article in European heart journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT06208501 (The Predictive Role of Proteomics in Blood Pressure Response of Hypertensive Patients Undergoing Renal Denervation.), which is not on this map. Cited by 36 papers, 2 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 2 pooled it
11.4field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
The Predictive Role of Proteomics in Blood Pressure Response of Hypertensive Patients Undergoing Renal Denervation.
Who cites it
36 citing papers in PubMed, 2 syntheses or guidelines pooled it, 93 citations in OpenAlex.
- Effects of Catheter-Based Renal Denervation in Hypertension: A Systematic Review and Meta-Analysis.Circulation · 2024Pooled it
- Randomized trials of invasive cardiovascular interventions that include a placebo control: a systematic review and meta-analysis.European heart journal · 2020Pooled it
- Trial
- Twenty-Four-Hour Pulsatile Hemodynamics Predict Brachial Blood Pressure Response to Renal Denervation in the SPYRAL HTN-OFF MED Trial.Hypertension (Dallas, Tex. : 1979) · 2022Trial
- Changes in blood pressure after crossover to ultrasound renal denervation in patients initially treated with sham in the RADIANCE-HTN SOLO trial.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2021Trial
- Effect of renal denervation in attenuating the stress of morning surge in blood pressure: post-hoc analysis from the SPYRAL HTN-ON MED trial.Clinical research in cardiology : official journal of the German Cardiac Society · 2021Trial
- Prioritised endpoints for device-based hypertension trials: the win ratio methodology.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2021Trial
- Renal denervation revisited: is patient selection the missing link between failure and success?Clinical hypertension · 2026Review
- Central nervous system mechanisms of salt-sensitive hypertension.Physiological reviews · 2025Review
- Renal denervation for hypertension.Nature reviews. Cardiology · 2025Review
- Novel approaches to define responders to interventional treatment in hypertension: insights from the SPYRAL HTN-OFF and HTN-ON MED trials.Hypertension research : official journal of the Japanese Society of Hypertension · 2025Review
- Response of Blood Pressure to Renal Denervation Is Not Associated With Genetic Variants.Hypertension (Dallas, Tex. : 1979) · 2025Article
- Efficacy of ultrasound renal denervation reducing blood pressure: a systematic review and meta-analysis.REC, interventional cardiology · 2025Article
- Real-world experience with ultrasound renal denervation utilizing home blood pressure monitoring: the Global Paradise System registry study design.Clinical research in cardiology : official journal of the German Cardiac Society · 2024Observational
- Device's design and clinical perspectives for resistant hypertension therapy.International journal of cardiology. Cardiovascular risk and prevention · 2024Review
- Renal Denervation as a Complementary Treatment Option for Uncontrolled Arterial Hypertension: A Situation Assessment.Journal of clinical medicine · 2023Review
- Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI).EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2023Article
- The enigma of resistant hypertension: from lifestyle changes and pharmacological treatment to renal denervation.European heart journal supplements : journal of the European Society of Cardiology · 2022Article
- Device-Based Therapy for Resistant Hypertension: An Up-to-Date Review.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2022Review
- Long-term efficacy and safety of renal denervation: another brick for building a hybrid therapy for hypertension?EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2022Article
Corrections and comments
- Erratum issued
Authors and funding
31 authors at 20 institutions in 14 countries.
Felix MahfoudKlinik für Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinikum des Saarlandes, Saarland University, Homburg, Germany.
Michel AziziUniversité de Paris, INSERM CIC1418, F-75015 Paris, France.
Sebastian EwenKlinik für Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinikum des Saarlandes, Saarland University, Homburg, Germany.
Atul PathakF-CRIN INI-CRCT Network, Nancy, France.
Christian UkenaKlinik für Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinikum des Saarlandes, Saarland University, Homburg, Germany.
Peter J BlankestijnUMC Utrecht, Utrecht, The Netherlands.
Michael BöhmKlinik für Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinikum des Saarlandes, Saarland University, Homburg, Germany.
Michel BurnierUniversity of Lausanne, Lausanne, Switzerland.
Gilles ChatellierUniversité de Paris, INSERM CIC1418, F-75015 Paris, France.
Isabelle Durand ZaleskiAssistance Publique Hopitaux de Paris, URCEco Hotel Dieu, Paris, France.
Guido GrassiClinica Medica, University of Milano Bicocca, Milan, Italy.
Michael JonerDeutsches Herzzentrum München, Munich, Germany.
David E KandzariPiedmont Heart Institute, Atlanta, GA, USA.
Ajay KirtaneColumbia University Irving Medical Center/NewYork-Presbyterian Hospital and the Cardiovascular Research Foundation, New York, NY, USA.
Sverre E KjeldsenUllevaal Hospital Oslo University, Oslo, Norway.
Melvin D LoboWilliam Harvey Research Institute, Centre for Clinical Pharmacology, Barts NIHR Cardiovascular Biomedical Research Centre, Queen Mary University of London, London, UK.
Thomas F LüscherCenter for Molecular Cardiology, Schlieren Campus, Zürich, Switzerland.
John William McEvoyNational University of Ireland Galway, Galway, Ireland.
Gianfranco ParatiDepartment of Medicine and Surgery, University of Milano-Bicocca-Istituto Auxologico Italiano, IRCCS, Milano, Italy.
Patrick RossignolF-CRIN INI-CRCT Network, Nancy, France.
Luis RuilopeInstitute of Research i+12 and CIBER CV, Hospital 12 de Octubre and Faculty of Sport Medicine, European University, Madrid, Spain.
Markus P SchlaichDobney Hypertension Centre, The University of Western Australia-Royal Perth Hospital Campus, Perth, Australia.
Atif ShahzadNational University of Ireland Galway, Galway, Ireland.
Faisal SharifNational University of Ireland Galway, Galway, Ireland.
Andrew S P SharpUniversity Hospital of Wales, Cardiff, UK.
Horst SievertCardioVascular Center Frankfurt CVC, Frankfurt, Germany.
Massimo VolpeSapienza University of Rome-Sant'Andrea Hospital Rome and IRCCS Neuromed, Pozzilli, Italy.
Michael A WeberSUNY Downstate College of Medicine, New York, NY, USA.
Roland E SchmiederDepartment of Nephrology and Hypertension, University Hospital, Erlangen, Germany.
Costas TsioufisFirst Cardiology Clinic, Medical School, National and Kapodistrian University of Athens, Hippokration Hospital, Athens, Greece.
William WijnsThe Lambe Institute for Translational Medicine, National University of Ireland Galway, Galway, Ireland.
Ollscoil na Gaillimhe – University of Galway · IEUniversitätsklinikum des Saarlandes · DEInserm · FRAssistance Publique – Hôpitaux de Paris · FRBaker Heart and Diabetes Institute · AUCentro de Investigación en Red en Enfermedades Cardiovasculares · ESDeutsches Herzzentrum der Charité · DEHarefield Hospital · GBIRCCS Istituto Auxologico Italiano · ITIstituto Neurologico Mediterraneo · ITNational and Kapodistrian University of Athens · GRNewYork–Presbyterian Hospital · USOslo University Hospital · NOPiedmont Atlanta Hospital · USPrincess Grace Hospital Centre · MCQueen Mary University of London · GBSUNY Downstate Health Sciences University · USUniversitätsklinikum Erlangen · DEUniversity of Applied Sciences Utrecht · NLUniversity of California, San Francisco · US
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
HypertensionHumansMedical History Taking
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390
Registered trials
NCT06208501ClinicalTrials.gov
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.